Add to Basket Bulk discount
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

P-glycoprotein antibody

Antigen

P-glycoprotein

Clonality Monoclonal (17F9)
Host

Mouse

Reactivity

Human

Application
Flow Cytometry (FACS), Immunoprecipitation (IP), Western Blotting (WB)
3 references available
Catalog no. ABIN967562
Quantity 0.1 mg  (0.5 mg/ml)
Price Product not available in this region.
Bulk discount
Shipping to

Additional Information

Format Liquid
Isotype IgG2b, kappa
Clone 17F9
Description Reacts with a 170-180 kDa transmembrane glycoprotein (P-glycoprotein), a product of the multidrug resistance-1 (MDR1) gene. This glycoprotein is expressed on MDR positive cells and has been reported to be expressed on many normal tissues, such as adrenal glands and endothelium, in the brain and skin. P-glycoprotein is known to impart drug resistance to cells by pumping many anti-cancer drugs out of the cytoplasm. 17F9 antibody binds to the surface of the viable, unfixed MDR+ cell line, PMG-Y (please inquire), and is able to partially block the binding of UIC2 antibody (another MDR-specific monoclonal antibody). Immunoprecipitation application is reported, but not routinely tested in house.
Synonyms: MDR
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.

Application Details

Application Notes Positive control cells are available through special order
Concentration 0.5 mg/ml
Purity Purified
Purification Purified from tissue culture supernatant or ascites by affinity chromatography.
Buffer Aqueous buffered solution.
Preservative 0.09% Sodium azide.
Storage Store undiluted at 4° C.
Restrictions For Research Use only

Publications

Product Bénard, Bourhis, Riou: "Clinical significance of multiple drug resistance in human cancers." in: Anticancer research, Vol. 10, Issue 5A, pp. 1297-302, 1990 (PubMed).

Goldstein, Galski, Fojo et al.: "Expression of a multidrug resistance gene in human cancers." in: Journal of the National Cancer Institute, Vol. 81, Issue 2, pp. 116-24, 1989 (PubMed).

Shi, Wrin, Reeder et al.: "High-affinity monoclonal antibodies against P-glycoprotein." in: Clinical immunology and immunopathology, Vol. 76, Issue 1 Pt 1, pp. 44-51, 1995 (PubMed).